Trades on 1 secondary market

Evox Therapeutics

Evox Therapeutics is an Oxford, United Kingdom based biotechnology company developing genetic medicines that expand the reach of gene therapy into the brain to transform the treatment landscape for severe neurodegenerative diseases. Its proprietary ExoEdit platform combines the natural transport cap

minimal 11.2 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Gene Therapy Genetic Medicine Exosomes

Evox Therapeutics is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.